PT Diagnos Laboratorium Utama Tbk (DGNS.JK)
IDR 210.0
(0.0%)
IDR 210.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 145.69 Billion | 192.88 Billion | 302.18 Billion | 183.17 Billion | 51.33 Billion | 38.55 Billion |
| Cost of Revenue | 86.38 Billion | 104.48 Billion | 154.53 Billion | 97.26 Billion | 31.85 Billion | 22.01 Billion |
| Gross Profit | 59.31 Billion | 88.39 Billion | 147.64 Billion | 85.9 Billion | 19.48 Billion | 16.53 Billion |
| Operating Expenses | 72.8 Billion | 70.73 Billion | 66.36 Billion | 18.87 Billion | 6.28 Billion | 4.09 Billion |
| Selling, General and Administrative Expenses | 73.41 Billion | 70 Billion | 66.09 Billion | 18.28 Billion | 5.85 Billion | 4.09 Billion |
| Research and Development Expenses | 249.04 Million | 586.17 Million | 273.57 Million | 593.35 Million | 425.89 Million | - |
| Other Expenses | -154.59 Million | -143.98 Million | - | - | - | - |
| Cost and Expenses | 159.18 Billion | 175.22 Billion | 220.9 Billion | 116.14 Billion | 38.13 Billion | 26.11 Billion |
| Operating Income | -15.15 Billion | 17.65 Billion | 81.27 Billion | 67.02 Billion | 13.2 Billion | 12.43 Billion |
| Interest Expense | 475.23 Million | 817.97 Million | - | - | - | - |
| Income Tax Expense | 83 Million | 4.66 Billion | 18.97 Billion | 14.28 Billion | 3.36 Billion | 2.96 Billion |
| Earnings before Tax | -13.57 Billion | 17.33 Billion | 83.27 Billion | 66.97 Billion | 12.64 Billion | 12.22 Billion |
| Net Income | -13.65 Billion | 12.66 Billion | 64.3 Billion | 52.68 Billion | 9.27 Billion | 9.26 Billion |
| Earnings Per Share Basic | -10.92 | 10.13 | 51.84 | 42.15 | 7.42 | 7.41 |
| Earnings Per Share Diluted | -10.92 | 10.13 | 51.84 | 42.15 | 7.42 | 7.41 |
| Weighted Average Shares Outstanding | 1.25 Billion | 1.25 Billion | 1.24 Billion | 1.25 Billion | 1.25 Billion | 1.25 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.25 Billion | 1.25 Billion | 1.24 Billion | 1.25 Billion | 1.25 Billion | 1.25 Billion |
| Gross Margin | 0.41 | 0.46 | 0.49 | 0.47 | 0.38 | 0.43 |
| EBIT Margin | 0.01 | 0.16 | 0.29 | 0.39 | 0.30 | 0.33 |
| Profit Margin | -0.09 | 0.07 | 0.21 | 0.29 | 0.18 | 0.24 |
| EBITDA | 1.53 Billion | 31.38 Billion | 90.84 Billion | 70.81 Billion | 14.89 Billion | 12.63 Billion |
| Earnings Before Tax Margin | -0.10 | 0.09 | 0.27 | 0.37 | 0.26 | 0.32 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 39.3 Billion | 41.74 Billion | 38.58 Billion | 145.69 Billion | 35.9 Billion | 33.57 Billion |
| Cost of Revenue | 24.27 Billion | 24.88 Billion | 23.75 Billion | 94.05 Billion | 23.66 Billion | 22.66 Billion |
| Gross Profit | 15.02 Billion | 16.86 Billion | 14.82 Billion | 51.64 Billion | 12.24 Billion | 10.9 Billion |
| Operating Expenses | 15.14 Billion | 16.19 Billion | 17.64 Billion | 65.67 Billion | 15.13 Billion | 15.54 Billion |
| Selling, General and Administrative Expenses | 15.1 Billion | 15.96 Billion | 17.46 Billion | - | 15.11 Billion | 15.54 Billion |
| Research and Development Expenses | 45.22 Million | 235.2 Million | 30.4 Million | - | 26.11 Million | 192.52 Million |
| Other Expenses | - | - | -147.94 Million | -154.59 Million | -100 Thousand | - |
| Cost and Expenses | 39.42 Billion | 41.07 Billion | 41.39 Billion | 159.72 Billion | 38.8 Billion | 38.21 Billion |
| Operating Income | -120.11 Million | 668.06 Million | -2.81 Billion | -14.03 Billion | -2.89 Billion | -4.64 Billion |
| Interest Expense | 210.39 Million | 211.33 Million | 365.67 Million | 475.23 Million | 58.81 Million | 27.92 Million |
| Income Tax Expense | -1.1 Billion | 3.00 | 246.33 Million | 83 Million | -102.45 Million | -90.46 Million |
| Earnings before Tax | -168.92 Million | 217.84 Million | -2.75 Billion | -13.57 Billion | -3.01 Billion | -4.36 Billion |
| Net Income | 940.04 Million | 217.84 Million | -3 Billion | -13.65 Billion | -2.91 Billion | -4.27 Billion |
| Earnings Per Share Basic | 0.75 | 0.17 | -2.40 | - | -2.33 | -3.42 |
| Earnings Per Share Diluted | 0.75 | 0.17 | -2.40 | - | -2.33 | -3.42 |
| Weighted Average Shares Outstanding | 1.25 Billion | 1.25 Billion | 1.25 Billion | 1.25 Billion | 1.25 Billion | 1.25 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.25 Billion | 1.25 Billion | 1.25 Billion | 1.25 Billion | 1.25 Billion | 1.25 Billion |
| Gross Margin | 0.38 | 0.40 | 0.38 | 0.35 | 0.34 | 0.32 |
| EBIT Margin | 0.09 | 0.10 | 0.02 | - | 0.02 | -0.03 |
| Profit Margin | 0.02 | 0.01 | -0.08 | -0.09 | -0.08 | -0.13 |
| EBITDA | 3.56 Billion | 4.31 Billion | 691.54 Million | - | 752.2 Million | -925.7 Million |
| Earnings Before Tax Margin | -0.00 | 0.02 | -0.07 | -0.10 | -0.08 | -0.14 |
NYR
RBD
JBI
LPA
MCD
LUVU